Update: Pacira Biosciences Shareholder Seeks Board Changes, Pushes for Sale

MT Newswires Live01-01

(Updates with Pacira's reply in the third paragraph.)

Pacira Biosciences (PCRX) shareholder, DOMA Perpetual Capital Management, said Tuesday that it plans to nominate three independent director candidates at the company's annual meeting in 2026.

DOMA said it owns about 6.83% of the company's shares and added that it is also calling for an immediate sale of the company, arguing that executive pay and overall spending are "exorbitant and unmerited" and that the board has not provided proper fiduciary oversight.

"Our Board is committed to enhancing long-term shareholder value and we take seriously feedback from our shareholders," Pacira Biosciences told MT Newswires, adding that it remains focused on carrying out its 5x30 strategy to drive growth.

Price: 26.15, Change: +0.08, Percent Change: +0.31

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2600703628?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-01 01:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2600703628","market":"sg","top_or_hot":-1,"title":"Update: Pacira Biosciences Shareholder Seeks Board Changes, Pushes for Sale","media":"MT Newswires Live","content":"<html><body><p> (Updates with Pacira's reply in the third paragraph.)</p><p>Pacira Biosciences (PCRX) shareholder, DOMA Perpetual Capital Management, said Tuesday that it plans to nominate three independent director candidates at the company's annual meeting in 2026.</p><p>DOMA said it owns about 6.83% of the company's shares and added that it is also calling for an immediate sale of the company, arguing that executive pay and overall spending are \"exorbitant and unmerited\" and that the board has not provided proper fiduciary oversight.</p><p>\"Our Board is committed to enhancing long-term shareholder value and we take seriously feedback from our shareholders,\" Pacira Biosciences told MT Newswires, adding that it remains focused on carrying out its 5x30 strategy to drive growth.</p><p>Price: 26.15, Change: +0.08, Percent Change: +0.31</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Update: Pacira Biosciences Shareholder Seeks Board Changes, Pushes for Sale</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUpdate: Pacira Biosciences Shareholder Seeks Board Changes, Pushes for Sale\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-01-01 01:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> (Updates with Pacira's reply in the third paragraph.)</p><p>Pacira Biosciences (PCRX) shareholder, DOMA Perpetual Capital Management, said Tuesday that it plans to nominate three independent director candidates at the company's annual meeting in 2026.</p><p>DOMA said it owns about 6.83% of the company's shares and added that it is also calling for an immediate sale of the company, arguing that executive pay and overall spending are \"exorbitant and unmerited\" and that the board has not provided proper fiduciary oversight.</p><p>\"Our Board is committed to enhancing long-term shareholder value and we take seriously feedback from our shareholders,\" Pacira Biosciences told MT Newswires, adding that it remains focused on carrying out its 5x30 strategy to drive growth.</p><p>Price: 26.15, Change: +0.08, Percent Change: +0.31</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2600703628","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2600703628","pubTimestamp":1767200441,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Pacira Biosciences  shareholder, DOMA Perpetual Capital Management, said Tuesday that it plans to nominate three independent director candidates at the company's annual meeting in 2026.DOMA said it owns about 6.83% of the company's shares and added that it is also calling for an immediate sale of the company, arguing that executive pay and overall spending are \"exorbitant and unmerited\" and that the board has not provided proper fiduciary oversight.\"Our Board is committed to enhancing long-term shareholder value and we take seriously feedback from our shareholders,\" Pacira Biosciences told MT Newswires, adding that it remains focused on carrying out its 5x30 strategy to drive growth.Price: 26.15, Change: +0.08, Percent Change: +0.31","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","PCRX":"Pacira Pharmaceuticals"},"translate_title":"更新：Pacira Biosciences股东寻求董事会变动，推动出售","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PCRX":1},"content_text":"(Updates with Pacira's reply in the third paragraph.)Pacira Biosciences (PCRX) shareholder, DOMA Perpetual Capital Management, said Tuesday that it plans to nominate three independent director candidates at the company's annual meeting in 2026.DOMA said it owns about 6.83% of the company's shares and added that it is also calling for an immediate sale of the company, arguing that executive pay and overall spending are \"exorbitant and unmerited\" and that the board has not provided proper fiduciary oversight.\"Our Board is committed to enhancing long-term shareholder value and we take seriously feedback from our shareholders,\" Pacira Biosciences told MT Newswires, adding that it remains focused on carrying out its 5x30 strategy to drive growth.Price: 26.15, Change: +0.08, Percent Change: +0.31","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2600703628","isCrawlerRequest":true}